Meta-analysis of clinical outcomes of intravenous recombinant tissue plasminogen activator for acute ischemic stroke: within 3 hours versus 3–4.5 hours

Author： Li Bing-Hu   Ding Xin   Yin Yan-Wei   Liu Yun   Gao Chang-Yue   Zhang Li-Li   Li Jing-Cheng  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.29, Iss.9, 2013-09, pp. : 1105-1114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

X. Pan et al.

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 3, 2015-04 ,pp. : 317-323

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 16, Iss. 7, 2016-07 ,pp. : 843-849

John Wiley & Sons Inc

Access to resources Recommend Favorite

Protocol for the perfusion and angiography imaging sub‐study of the Third International Stroke Trial (IST‐3) of alteplase treatment within six‐hours of acute ischemic stroke

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 6, 2015-08 ,pp. : 956-968

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tissue plasminogen activator for acute ischemic stroke: Is the CAEP Position Statement too negative?

By  

Canadian Journal of Emergency Medicine, Vol. 3, Iss. 3, 2001-07 ,pp. : 183-185

Cambridge University Press

Access to resources Recommend Favorite

Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST‐ER): design and methodology of a multinational phase 3 trial

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 7, 2015-10 ,pp. : 1141-1148

John Wiley & Sons Inc

Access to resources Recommend Favorite